NCT05014789View on ClinicalTrials.gov

Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study

NACompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 19, 2021

Primary Completion Date

December 20, 2021

Study Completion Date

December 20, 2021

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Control-IQ technology 2.0

All subjects wearing the t:slim X2 insulin pump with Control-IQ technology 2.0, and wearing the Dexcom G6 sensor

Trial Locations (1)

22904

University of Virginia, Charlottesville

All Listed Sponsors
lead

Tandem Diabetes Care, Inc.

INDUSTRY

NCT05014789 - Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study | Biotech Hunter | Biotech Hunter